Journal of Heavy Metal Toxicity and Diseases Open Access

  • ISSN: 2473-6457
  • Journal h-index: 8
  • Journal CiteScore: 5.69
  • Journal Impact Factor: 3.69
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Copper therapy

Copper therapy is aimed at removing excess accumulated copper and preventing its reaccumulation. Copper overload results in Wilson disease. Chelation therapy drugs approved for treating Wilson disease include penicillamine (Cuprimine® and Depen®) and trientine (Syprine® and Trientine Dihydrochloride) both of these drugs act by chelation or binding of copper, causing its increased urinary excretion.

High Impact List of Articles
Conference Proceedings